Mathematical Modelling for the Role of CD4⁺T Cells in Tumor-Immune Interactions

Abstract

Mathematical modelling has been used to study tumor-immune cell interaction. Some models were proposed to examine the effect of circulating lymphocytes, natural killer cells, and CD8+T cells, but they neglected the role of CD4+T cells. Other models were constructed to study the role of CD4+T cells but did not consider the role of other immune cells. In this study, we propose a mathematical model, in the form of a system of nonlinear ordinary differential equations, that predicts the interaction between tumor cells and natural killer cells, CD4+T cells, CD8+T cells, and circulating lymphocytes with or without immunotherapy and/or chemotherapy. This system is stiff, and the Runge–Kutta method failed to solve it. Consequently, the “Adams predictor-corrector” method is used. The results reveal that the patient’s immune system can overcome small tumors; however, if the tumor is large, adoptive therapy with CD4+T cells can be an alternative to both CD8+T cell therapy and cytokines in some cases. Moreover, CD4+T cell therapy could replace chemotherapy depending upon tumor size. Even if a combination of chemotherapy and immunotherapy is necessary, using CD4+T cell therapy can better reduce the dose of the associated chemotherapy compared to using combined CD8+T cells and cytokine therapy. Stability analysis is performed for the studied patients. It has been found that all equilibrium points are unstable, and a condition for preventing tumor recurrence after treatment has been deduced. Finally, a bifurcation analysis is performed to study the effect of varying system parameters on the stability, and bifurcation points are specified. New equilibrium points are created or demolished at some bifurcation points, and stability is changed at some others. Hence, for systems turning to be stable, tumors can be eradicated without the possibility of recurrence. The proposed mathematical model provides a valuable tool for designing patients’ treatment intervention strategies.

Potential of Immunotherapies in Treating Hematological Cancer-Infection Comorbidities—A Mathematical Modelling Approach

“…This corresponds to 0.5 × 10 −3 -2 × 10 −2 per day. Thus, we choose a x = 1.25 × 10 −3 per day, which is slow compared to most other cancers (for which a x lies between 0.01-1.5 per day [29,34,55,59,[62][63][64][65][66][67][68]).…”

“…Across various cancers, the values of the product r x • p x varies ranging from 5 × 10 −11 -0.5 per day [34,[62][63][64][65][66]68]. Kuznetsov [28,29] took a value for p x near to but smaller than 1, e.g., 0.998, for BCL1 lymphoma in non-chimeric mice based on data from [72].…”

“…Natural death rates for active cytotoxic T-cells are reported to be in the range 4.12 × 10 −2 -0.12 per day [62,[64][65][66]73]. We chose d x = 0.4 per day.…”

Lyapunov function and global asymptotic stability for a new multiscale viral dynamics model incorporating the immune system response: Implemented upon HCV

“…Mathematical modeling is a useful tool to study and analyze many engineering and physical problems. It has also been used to describe some biological processes such as heartbeats [ 9 ], tumor growth and cancer treatment [ 10 , 11 ], and virus dynamics for many types of viruses such as HCV, HBV, HIV, and Covid-19 [ 12 – 14 ]. It provides a powerful tool in the study of virus dynamics because it helps to understand the biological mechanisms and interpret the experimental results.…”

The Perspective of Acquired Immunity to Combat against Infectious Diseases: An Overview

“…A British study published in The Lancet medical journal looked at levels of neutralizing antibodies produced in vaccinated people exposed to the Delta, Alpha, and Beta variants [4]. A scientific, clinical, and epidemiological studies show the impact of physical exercise on the immune system [5], but no significant mathematical studies show the effects of physical activity [6]. The physical body is usually at war with outside threats like viruses, bacteria, fungi, toxins, and parasites.…”